Case Report · pages 99–100
Sildenafil in the Treatment of Primary Pulmonary Hypertension: A Case Report
Cite this article
N.S. Neki. Sildenafil in the Treatment of Primary Pulmonary Hypertension: A Case Report. J Int Med Sci Acad. 2009;22(2):99–100.
Opening of the article
Pulmonary arterial hypertension (PAH) is a life threatening, progressive and often fatal, debilitating disorder with a grave prgnosis. The increased pulmonary artery(PA) pressure found in P AH is due to disturbances in key vascular mediator pathways including relative deficiencies of vasodilators like nitric oxide (NO) and prostacycline, as well as increased production of vasoconstrictors like endothelin and thromoboxanes.
